Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-02-01 Purchase | 2024-02-06 10:27 am | CNS Pharmaceuticals Inc. | CNSP | Downs Christopher Chief Financial Officer | 66,666 | $0.3 | $20,000 | 359,916 (Direct) | View |
| 2023-08-22 Purchase | 2023-08-23 08:00 am | CNS Pharmaceuticals Inc. | CNSP | Downs Christopher Chief Financial Officer | 27,000 | $1.2658 | $34,177 | 36,772 (Direct) | View |
| 2023-04-17 Purchase | 2023-04-18 08:00 am | CNS Pharmaceuticals Inc. | CNSP | Downs Christopher Chief Financial Officer | 3,100 | $3.2 | $9,920 | 9,251 (Direct) | View |
| 2021-12-06 Purchase | 2021-12-07 08:30 am | CNS Pharmaceuticals Inc. | CNSP | Downs Christopher Chief Financial Officer | 5,000 | $0.9403 | $4,702 | 151,500 (Direct) | View |
| 2021-11-19 Purchase | 2021-11-22 08:47 am | CNS Pharmaceuticals Inc. | CNSP | Downs Christopher Chief Financial Officer | 4,500 | $1.1537 | $5,192 | 146,500 (Direct) | View |
| 2020-08-24 Purchase | 2020-08-25 7:11 pm | CNS Pharmaceuticals Inc. | CNSP | Downs Christopher Chief Financial Officer | 142,000 | $2.04 | $289,680 | 142,000 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-04-08 Option Award | 2024-04-10 9:51 pm | N/A 2034-04-08 | CNS Pharmaceuticals Inc. | CNSP | Downs Christopher Chief Financial Officer | 80,000 | $0 | 443 (Direct) | View |
| 2024-02-01 Option Award | 2024-02-06 10:27 am | 2024-02-01 2029-02-01 | CNS Pharmaceuticals Inc. | CNSP | Downs Christopher Chief Financial Officer | 133,332 | $0 | 359,916 (Direct) | View |
| 2023-04-28 Exercise | 2023-05-01 6:59 pm | N/A N/A | CNS Pharmaceuticals Inc. | CNSP | Downs Christopher Chief Financial Officer | 521 | $0 | 38,020 (Direct) | View |
| 2023-03-29 Option Award | 2023-03-31 7:28 pm | N/A N/A | CNS Pharmaceuticals Inc. | CNSP | Downs Christopher Chief Financial Officer | 6,067 | $0 | 28,768 (Direct) | View |
| 2023-02-09 Exercise | 2023-02-10 5:34 pm | N/A N/A | EBET Inc. | EBET | Downs Christopher Director | 6,300 | $0 | 81,300 (Direct) | View |
| 2022-04-28 Option Award | 2022-04-29 5:12 pm | N/A N/A | CNS Pharmaceuticals Inc. | CNSP | Downs Christopher Chief Financial Officer | 250,000 | $0 | 681,000 (Direct) | View |
| 2022-03-11 Option Award | 2022-03-14 09:40 am | N/A N/A | CNS Pharmaceuticals Inc. | CNSP | Downs Christopher Chief Financial Officer | 33,000 | $0.31 | 184,500 (Direct) | View |
| 2022-02-09 Option Award | 2022-02-11 4:36 pm | N/A N/A | Esports Technologies Inc. | EBET | Downs Christopher Director | 6,300 | $0 | 81,300 (Direct) | View |
Ownership | 2021-04-14 9:52 pm | N/A 2031-03-05 | Esports Technologies Inc. | EBET | Downs Christopher Director | 0 | $0 | 75,000 (Direct) | View |
| 2021-02-05 Option Award | 2021-02-09 5:00 pm | N/A 2031-02-05 | CNS Pharmaceuticals Inc. | CNSP | Downs Christopher Chief Financial Officer | 131,000 | $0 | 431,000 (Direct) | View |